Log in to save to my catalogue

A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer

A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_58a7f425e1414bdd9a00df059ccf5074

A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer

About this item

Full title

A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-02, Vol.14 (1), p.3198-3198, Article 3198

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Bladder cancer (BLCA) is a malignant tumor associated with unfavorable outcomes. Studies suggest that anoikis plays a crucial role in tumor progression and cancer cell metastasis. However, its specific role in bladder cancer remains poorly understood. Our objective was to identify anoikis-related genes (ARGs) and subsequently construct a risk model...

Alternative Titles

Full title

A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_58a7f425e1414bdd9a00df059ccf5074

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_58a7f425e1414bdd9a00df059ccf5074

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-53272-0

How to access this item